Financial analysts covering the Claranova share (CLA.PA)
Outlining the vision for Avanquest
Transition to pure play software business ongoing
Better profitability in H125
Weak Q1 leads us to cut our FY 2026 estimates
FY 2024/25 review: First take
Still an appealing story, execution key
Decline in activity in Q1 due to continued focus on profitability
Mixed FY results, but difficult to interpret due to the group’s refocusing
Disappointing Q4 sales but ambitious new roadmap for 2028
